登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： 1．2026年2月26日，华闻传媒投资集团股份有限公司（以下简称"公司"）收到海南省海口市中级人民法 院（以下简称"海口中院"或"法院"）送达的《民事裁定书》[（2024）琼01破申70号]，裁定受理公司债 权人三亚凯利投资有限公司（以下简称"三亚凯利"）对公司的重整申请。 2．因海口中院依法裁定受理债权人对公司的重整申请，根据《深圳证券交易所股票上市规则》第9.4.1 条第（九）项的规定，公司股票交易将于2026年3月2日被实施退市风险警示，股票简称变更为"*ST华 闻"，证券代码仍为"000793"，股票日涨跌幅限制仍为5%。根据《深圳证券交易所股票上市规则》第 9.4.9条的规定，公司股票将于2026年2月27日开市起停牌一天，自2026年3月2日开市起复牌。 3．海口中院已裁定公司进入重整程序，但公司仍存在因重整失败而被宣告破产的风险。如果法院裁定 公司破产，公司将被实施破产清算，根据《深圳证券交易所股票上市规则》第9.4.18条第（八）项的规 ...

Group 1 - The company has changed its name from "有棵树" to "行云科技" effective February 13, while maintaining the same stock code 300209, to align with its current business development needs and highlight the brand of its industrial investor, 行云集团 [1] - The actual controller and director, Wang Wei, plans to increase his shareholding in the company by an amount not less than 50 million RMB and not more than 100 million RMB within the next six months, reflecting his confidence in the company's business recovery prospects post-restructuring [1][2] - The company has completed its restructuring plan as confirmed by the Changsha Intermediate People's Court in December 2024, marking a new phase of standardized governance and industrial restructuring [1] Group 2 - The name change is intended to facilitate the industrial investor, Shenzhen Tianxingyun Supply Chain Co., Ltd., in fulfilling its commitments under the restructuring plan, ensuring alignment between the company's name, positioning, and strategic planning [2] - The planned share increase by Wang Wei is aimed at enhancing investor confidence in the capital market and consolidating shareholder support to focus on core business and improve profitability [2]

业务进展情况 公司正积极转型新能源，如2025年11月获得26.25万千瓦风电项目核准并布局氢能领域。未来需跟踪项 目落地和业务贡献度。 业绩经营情况 赫美集团于2026年1月30日发布业绩预告，预计2025年全年归属于上市公司股东的净利润为2800万元至 4200万元，实现扭亏为盈，主要因补能业务规模化盈利、服饰业务亏损收窄及非经常性损益影响。正式 年度报告预计将在2026年一季度内披露，需关注最终财务数据确认。 公司状况 2025年12月，公司重整计划获通过，涉及资本公积金转增股本用于清偿债务和引进重整投资人。后续需 关注债务清偿、资金注入及业务整合的具体实施情况。 经济观察网 赫美集团（002356）近期披露2025年业绩预告实现扭亏为盈，同时公司重整计划获通过， 新能源业务亦有新进展。 股东人数情况 截至2026年1月31日，股东户数降至4.02万户，环比减少7.37%，反映筹码集中度提升。这可能影响市场 流动性及股价波动。 以上内容基于公开资料整理，不构成投资建议。 ...

Group 1 - The company has completed the implementation of the capital reserve transfer to increase share capital as part of its restructuring plan, with 4.145 billion shares registered and 6.5 billion yuan of restructuring funds paid in full [1] - The company is executing a compensation of 2.459 billion yuan to over 50,000 investors due to a securities false statement case, with compensation methods including cash, stocks, and trust income rights [2] - The company has initiated litigation against the former management and related responsible parties, with the case currently under court review [3] Group 2 - The company reported a revenue of 3.96 billion yuan and a net profit attributable to shareholders of 13 million yuan for the first three quarters of 2025, representing a year-on-year increase of 160.84% [4] - The company emphasizes traditional Chinese medicine as its core business, operating eight production bases and a "smart pharmacy" model, with over 600 intellectual property rights accumulated by mid-2025 [5]

Group 1 - The controlling shareholder of Ningbo Shanshan Co., Ltd., Shanshan Group, and its wholly-owned subsidiary, Ningbo Pengze Trading Co., Ltd., have been ordered to undergo substantive consolidation reorganization by the Ningbo Yinzhou District People's Court on March 20, 2025 [1] - On February 6, 2026, the company signed a reorganization investment agreement with the court-appointed administrator and reorganization investors [1] - The fourth creditors' meeting for the bankruptcy reorganization case is scheduled for March 2, 2026, to be held online [1] Group 2 - According to the reorganization investment agreement, the reorganization investors will control 21.88% of the voting rights of Shanshan Co., Ltd. through direct stock acquisition and concerted action arrangements [2] - If the reorganization is successful, the controlling shareholder will change to Anhui Wanwei Group Co., Ltd., and the actual controller will change to the State-owned Assets Supervision and Administration Commission of Anhui Province [2] - The outcome of the reorganization remains uncertain as the reorganization plan draft needs to be approved by the creditors' meeting and the court [2] Group 3 - The company emphasizes that there are currently no non-operating fund occupations or illegal guarantees harming the interests of the listed company by the controlling shareholder [2] - The company maintains independent business operations and has not experienced significant adverse effects on its daily operations due to the ongoing reorganization [2] - The company will continue to monitor the situation and fulfill its information disclosure obligations in accordance with relevant laws and regulations [2]

公司重整计划已于2025年12月执行完毕，形成约680亿元至700亿元的重整收益，计入非经常性损益。同 时，新任董事长郭伟及专家顾问团队(如马蔚华、冯仑等)已上任，重点推动资产盘活和业务转型。后续 关注点包括新战略(如投资管理、不动产运营)的落地效果。 公司基本面 尽管净利润扭亏，但2025年扣非净利润预计亏损290亿元至350亿元，反映主营业务仍承压。资金流向显 示，2026年1月主力资金净流出频繁，例如1月9日净流出1238.1万元，与大盘走势分化，表明市场对ST 个股持谨慎态度。长期表现需观察现金流改善及行业政策影响。 以上内容基于公开资料整理，不构成投资建议。 经济观察网根据最新公告和市场信息，ST金科(000656)有以下值得关注的事件： 业绩经营情况 公司于2026年1月30日发布业绩预告，预计2025年净利润为300亿元至350亿元，实现扭亏为盈；年末净 资产预计为50亿元至70亿元，由负转正。若经审计后符合条件，公司计划向深交所申请撤销退市风险警 示(即"摘帽")，最终结果取决于年报审计意见。2025年年度报告预计在近期披露，这将决定公司是否消 除退市风险。 重组进展 ...

Group 1 - The company name has been changed from "Youkeshu Technology Co., Ltd" to "Xingyun Technology Co., Ltd" [2] - The stock abbreviation has been changed from "Youkeshu" to "Xingyun Technology," effective from February 13, 2026 [3] - The company's stock code "300209" remains unchanged [4] Group 2 - The change in company name and stock abbreviation was approved during the board meeting on January 26, 2026, and the first extraordinary shareholders' meeting on February 11, 2026 [5] - The reason for the name change is to align with the company's strategic development plan following the completion of its restructuring process [6] - The company has completed the business registration change and obtained a new business license from the Changsha Market Supervision Administration [7] Group 3 - The actual controller and director, Mr. Wang Wei, plans to increase his shareholding in the company within six months, with an investment amount between RMB 50 million and RMB 100 million [14][15] - Mr. Wang Wei currently holds 91,852,462 shares, accounting for 9.89% of the total share capital, while he and his concerted actions hold a total of 167,154,503 shares, representing 18.00% of the total share capital [15] - The purpose of the shareholding increase is to enhance investor confidence and support the company's focus on its core business and profitability [16]

Core Viewpoint - Jintongling Technology Group Co., Ltd. has resumed trading after completing a capital reserve conversion and rights issue, indicating a positive outlook for its restructuring efforts [1] Group 1: Company Actions - Jintongling has completed a capital reserve conversion and rights issue, leading to the resumption of trading [1] - Huitongda Network has become the industrial investor in Jintongling's restructuring, acquiring 710 million shares at a price of 1.3996 yuan per share [1] Group 2: Market Reaction - The stock of Jintongling experienced active trading, with a peak increase of over 16% during the day [1] - The market's response reflects a significant valuation gap compared to Huitongda's investment cost, indicating positive expectations for Jintongling's restructuring prospects [1]

Core Viewpoint - Hunan Jingfeng Pharmaceutical Co., Ltd. is undergoing a restructuring process, which has led to a significant risk of downward adjustment in its stock price due to a capital reserve increase plan that will double the total share count [2][3][4]. Group 1: Stock Price Adjustment Risk - The company plans to implement a capital reserve increase by converting its capital reserve into shares at a ratio of 1:1, resulting in an increase of total shares from 879,774,351 to 1,759,548,702 [3]. - The newly issued shares will not be distributed to existing shareholders but will be acquired by restructuring investors, with funds used for bankruptcy costs, debt repayment, and working capital [3]. - The reference price for the stock's ex-rights adjustment will be calculated based on the average price of 2.34 yuan per share, with potential adjustments depending on the stock's closing price on the registration date [4]. Group 2: Restructuring Plan Execution - The Changde Intermediate People's Court has approved the company's restructuring plan and terminated the restructuring process, moving into the execution phase [2][5]. - If the company fails to execute the restructuring plan, it may face bankruptcy, which could lead to the termination of its stock listing [5]. - The company has reported negative net profits for the years 2022, 2023, and 2024, raising concerns about its ongoing viability and compliance with stock listing rules [6].

备受市场关注的 杉杉集团 第二轮重整迎来关键进展，一家由安徽国资和宁波国资组成的国 资联合体最终入局。 若重整投资方案顺利实施，杉杉股份（600884.SH）的实际控制权将 从民营资本正式转归国有。 杉杉股份2月8日晚间发布公告，公司收到杉杉集团管理人通知，经遴选，确定安徽皖维集 团有限责任公司（简称"皖维集团"）、安徽海螺集团有限责任公司(简称"海螺集团")和宁波 金融资产管理股份有限公司（简称"宁波金资"）组成的联合体中选；皖维集团和宁波金资 为杉杉集团和朋泽贸易的重整投资人。 据公告，杉杉集团及其全资子公司宁波朋泽贸易有限公司（简称"朋泽贸易"）、管理人与 重整投资人皖维集团、宁波金资已于2026年2月6日签署了《重整投资协议》。 值得关注的 是，同日杉杉股份股价涨停。 杉杉股份表示，如此次重整成功，公司的控制权将发生变更，其控控股股东将变更为皖维集 团， 公司实际控制人将变更为安徽省国资委。 皖维集团与宁波金资组成的联合体，是在杉杉集团于2025年11月因第一轮重整失败后，重 新公开招募意向投资人背景下，经遴选最终确定的重整投资人。联合体中另一重要主体安徽 海螺集团有限责任公司目前正在推进与皖维集团的 ...